| RS569947936 |
PMS2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary nonpolyposis colorectal neoplasms |
| RS569948031 |
RECQL4
|
Health Risk |
Likely pathogenic |
Baller-Gerold syndrome, Baller-Gerold syndrome |
| RS569955570 |
SACS
|
Health Risk |
Conflicting classifications of pathogenicity |
Charlevoix-Saguenay spastic ataxia, Spastic paraplegia |
| RS569973034 |
COL9A3
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS569973824 |
SYNE1
|
Health Risk |
Conflicting classifications of pathogenicity |
Emery-Dreifuss muscular dystrophy 4, autosomal dominant |
| RS569974617 |
DSP
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Cardiomyopathy |
| RS569974719 |
SH3TC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease type 4, Susceptibility to mononeuropathy of the median nerve |
| RS569981883 |
ALDOB
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary fructosuria, ALDOB-related disorder |
| RS569983068 |
ATM
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Ataxia-telangiectasia syndrome |
| RS569992163 |
KCNV2
|
Health Risk |
Pathogenic |
— |
| RS569997475 |
MANBA
|
Health Risk |
Conflicting classifications of pathogenicity |
Intellectual disability, Beta-D-mannosidosis |
| RS569997507 |
SPTAN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Self-limited epilepsy with centrotemporal spikes, Developmental and epileptic encephalopathy |
| RS570006227 |
POP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS570009776 |
COL4A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Brain small vessel disease 1 with or without ocular anomalies, Retinal arterial tortuosity |
| RS570010538 |
FLNC
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypertrophic cardiomyopathy 26, Myofibrillar myopathy 5 |
| RS570013652 |
PNKP
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 12 |
| RS570016062 |
SLC25A22
|
Health Risk |
Conflicting classifications of pathogenicity |
Early-infantile DEE, Early-infantile DEE |
| RS570020451 |
EYS
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinitis pigmentosa 25, Retinitis pigmentosa 25 |
| RS570022823 |
BARD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Familial cancer of breast |
| RS570036369 |
MET
|
Health Risk |
Conflicting classifications of pathogenicity |
Renal cell carcinoma, Hereditary cancer-predisposing syndrome |
| RS570039271 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiomyopathy, Cardiomyopathy |
| RS570041689 |
RPA1
|
Health Risk |
Pathogenic |
Pulmonary fibrosis and/or bone marrow failure, telomere-related |
| RS570042882 |
GLA
|
Health Risk |
Pathogenic/Likely pathogenic |
Fabry disease, Fabry disease |
| RS570046043 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS570047465 |
TYMP
|
Health Risk |
Conflicting classifications of pathogenicity |
Mitochondrial neurogastrointestinal encephalomyopathy, Mitochondrial DNA depletion syndrome 1 |
| RS570051117 |
ACTN2
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1AA, Primary familial hypertrophic cardiomyopathy |
| RS570056677 |
AGTR1
|
Health Risk |
Conflicting classifications of pathogenicity |
Essential hypertension, genetic |
| RS570058149 |
MYBPC3
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypertrophic cardiomyopathy 4, Left ventricular noncompaction 10 |
| RS570058270 |
GFI1B
|
Health Risk |
Likely pathogenic |
Platelet-type bleeding disorder 17, Platelet-type bleeding disorder 17 |
| RS570062125 |
RBP3
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS570065416 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis 2, Cervical cancer |
| RS570069789 |
NPHS1
|
Health Risk |
Likely pathogenic |
Finnish congenital nephrotic syndrome, Finnish congenital nephrotic syndrome |
| RS570076170 |
NPHP3
|
Health Risk |
Conflicting classifications of pathogenicity |
Renal-hepatic-pancreatic dysplasia 1, NPHP3-related Meckel-like syndrome |
| RS570078140 |
CC2D2A
|
Health Risk |
Conflicting classifications of pathogenicity |
Joubert syndrome, Meckel-Gruber syndrome |
| RS570079347 |
MYH7
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypertrophic cardiomyopathy, MYH7-related skeletal myopathy |
| RS570091335 |
PTCH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Gorlin syndrome, Hereditary cancer-predisposing syndrome |
| RS570097430 |
GLDC
|
Health Risk |
Pathogenic |
Glycine encephalopathy, Glycine encephalopathy 1 |
| RS570105218 |
CNPY3
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 60 |
| RS570106950 |
PIEZO1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, PIEZO1-related disorder |
| RS570110822 |
DCAF17
|
Health Risk |
Conflicting classifications of pathogenicity |
Woodhouse-Sakati syndrome, Woodhouse-Sakati syndrome |
| RS570111306 |
L2HGDH
|
Health Risk |
Likely pathogenic |
L-2-hydroxyglutaric aciduria, L-2-hydroxyglutaric aciduria |
| RS570116954 |
SYNE2
|
Health Risk |
Conflicting classifications of pathogenicity |
Emery-Dreifuss muscular dystrophy 5, autosomal dominant |
| RS570119913 |
AHNAK2
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS570123407 |
KCNQ3
|
Health Risk |
Conflicting classifications of pathogenicity |
Benign neonatal seizures, Benign neonatal seizures |
| RS570127242 |
LOXHD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive nonsyndromic hearing loss 77, Autosomal recessive nonsyndromic hearing loss 77 |
| RS570130189 |
PIEZO1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS570134110 |
NEB
|
Health Risk |
Conflicting classifications of pathogenicity |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS570136508 |
MUSK
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital myasthenic syndrome 9, Fetal akinesia deformation sequence 1 |
| RS570139975 |
KCNQ2
|
Health Risk |
Conflicting classifications of pathogenicity |
Early-infantile DEE, Early-infantile DEE |
| RS570143443 |
NDUFAF5
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS570149409 |
CFAP74
|
Health Risk |
Pathogenic |
Ciliary dyskinesia, primary |
| RS570157673 |
LSS
|
Health Risk |
Pathogenic |
Alopecia-intellectual disability syndrome 4, Alopecia-intellectual disability syndrome 4 |
| RS570167996 |
NOD2
|
Health Risk |
Conflicting classifications of pathogenicity |
Blau syndrome, Regional enteritis |
| RS570170859 |
DAB1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS570176656 |
RET
|
Health Risk |
Conflicting classifications of pathogenicity |
Multiple endocrine neoplasia, type 2 |
| RS570190374 |
CNTNAP2
|
Health Risk |
Conflicting classifications of pathogenicity |
Cortical dysplasia-focal epilepsy syndrome, Inborn genetic diseases |
| RS57019720 |
KRT9
|
Health Risk |
Pathogenic |
Epidermolytic palmoplantar keratoderma, 1 |
| RS570198729 |
ENG
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary hemorrhagic telangiectasia, Telangiectasia |
| RS570207081 |
CACNA1H
|
Health Risk |
Conflicting classifications of pathogenicity |
Idiopathic generalized epilepsy, Hyperaldosteronism |
| RS570209023 |
CIZ1
|
Health Risk |
Conflicting classifications of pathogenicity |
Dystonic disorder, Dystonic disorder |
| RS570210229 |
SUCLG1
|
Health Risk |
Pathogenic |
Mitochondrial DNA depletion syndrome 9, Mitochondrial DNA depletion syndrome 9 |
| RS570214336 |
STRA6
|
Health Risk |
Pathogenic |
Matthew-Wood syndrome, Matthew-Wood syndrome |
| RS570222177 |
RP1L1
|
Health Risk |
Conflicting classifications of pathogenicity |
Occult macular dystrophy, Occult macular dystrophy |
| RS570224404 |
SPTA1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS570231965 |
VARS2
|
Health Risk |
Conflicting classifications of pathogenicity |
Combined oxidative phosphorylation defect type 20, VARS2-related disorder |
| RS570233664 |
ACSF3
|
Health Risk |
Pathogenic/Likely pathogenic |
Combined malonic and methylmalonic acidemia, Combined malonic and methylmalonic acidemia |
| RS570248730 |
LRSAM1
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease axonal type 2P, Charcot-Marie-Tooth disease axonal type 2P |
| RS570264094 |
PRX
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease type 4, Inborn genetic diseases |
| RS570269920 |
COL5A2
|
Health Risk |
Conflicting classifications of pathogenicity |
Ehlers-Danlos syndrome, classic type |
| RS570277510 |
USH2A
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinal dystrophy, Usher syndrome type 2A |
| RS570278338 |
NSD1
|
Health Risk |
Pathogenic |
Sotos syndrome, Sotos syndrome |
| RS570278423 |
SDHB
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Pheochromocytoma |
| RS570278983 |
NSD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Sotos syndrome, NSD1-related disorder |
| RS570279865 |
SMAD6
|
Health Risk |
Pathogenic |
Radioulnar synostosis, Radioulnar synostosis |
| RS570279948 |
PROM1
|
Health Risk |
Likely pathogenic |
— |
| RS570281194 |
GHRHR
|
Health Risk |
Likely pathogenic |
Isolated growth hormone deficiency, type 4 |
| RS57028199 |
CBL
|
Health Risk |
Conflicting classifications of pathogenicity |
Noonan syndrome and Noonan-related syndrome, Noonan syndrome and Noonan-related syndrome |
| RS570294713 |
BAG3
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1HH, Myofibrillar myopathy 6 |
| RS570316231 |
MYO7A
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal dominant nonsyndromic hearing loss 11, Usher syndrome type 1 |
| RS570320774 |
COL2A1
|
Health Risk |
Conflicting classifications of pathogenicity |
16 conditions, Inborn genetic diseases |
| RS570335069 |
MAGEL2
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS570336313 |
TCIRG1
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive osteopetrosis 1, Autosomal recessive osteopetrosis 1 |
| RS570339629 |
CLCN7
|
Health Risk |
Conflicting classifications of pathogenicity |
Osteopetrosis, Osteopetrosis |
| RS570341380 |
ANO5
|
Health Risk |
Pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2L, Gnathodiaphyseal dysplasia |
| RS570341792 |
SYNE2
|
Health Risk |
Conflicting classifications of pathogenicity |
Emery-Dreifuss muscular dystrophy 5, autosomal dominant |
| RS570343418 |
WRAP53
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS570349090 |
LRPPRC
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital lactic acidosis, Saguenay-Lac-Saint-Jean type |
| RS570355453 |
RP1L1
|
Health Risk |
Conflicting classifications of pathogenicity |
Occult macular dystrophy, Inborn genetic diseases |
| RS570356711 |
KMT2E
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS570371168 |
HPS4
|
Health Risk |
Conflicting classifications of pathogenicity |
HPS4-related disorder, HPS4-related disorder |
| RS570378547 |
CHRNE
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital myasthenic syndrome 4A, Congenital myasthenic syndrome |
| RS570379164 |
SCN1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Migraine, familial hemiplegic |
| RS570380438 |
NPHP4
|
Health Risk |
Conflicting classifications of pathogenicity |
Nephronophthisis, Nephronophthisis |
| RS570382990 |
SLX4
|
Health Risk |
Conflicting classifications of pathogenicity |
Fanconi anemia, Fanconi anemia complementation group P |
| RS570388861 |
ABCC8
|
Health Risk |
Pathogenic/Likely pathogenic |
Hyperinsulinemic hypoglycemia, familial |
| RS57039241 |
TBX19
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital isolated adrenocorticotropic hormone deficiency, Congenital isolated adrenocorticotropic hormone deficiency |
| RS570401263 |
RAX
|
Health Risk |
Conflicting classifications of pathogenicity |
Isolated microphthalmia 3, Isolated microphthalmia 3 |
| RS570402166 |
TNXB
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS570408889 |
DYNC1H1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Charcot-Marie-Tooth disease axonal type 2O |
| RS570409651 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis 2, Hereditary cancer-predisposing syndrome |